Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status

F MACBETH; J BOLGER; P HOPWOOD; N BLEEHEN; J CARTMELL; D GIRLING; D MACHIN; R STEPHENS; A BAILEY

doi:10.1016/s0936-6555(96)80041-0

Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status

Clinical Oncology ◽

10.1016/s0936-6555(96)80041-0 ◽

1996 ◽

Vol 8 (3) ◽

pp. 167-175 ◽

Cited By ~ 161

Author(s):

F MACBETH ◽

J BOLGER ◽

P HOPWOOD ◽

N BLEEHEN ◽

J CARTMELL ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Trial ◽

Cell Lung Cancer ◽

Performance Status ◽

Small Cell ◽

Small Cell Lung ◽

Good Performance Status ◽

Fraction Versus

Download Full-text

Randomized trial of two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status

Clinical Oncology ◽

10.1016/s0936-6555(96)80101-4 ◽

1996 ◽

Vol 8 (6) ◽

pp. 408 ◽

Cited By ~ 1

Author(s):

F.A.P. Lander ◽

D.M.R. Ritchie

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Trial ◽

Cell Lung Cancer ◽

Performance Status ◽

Small Cell ◽

Small Cell Lung ◽

Good Performance Status ◽

Fraction Versus

Download Full-text

O-275 Ifosfamide, carboplatin and etoposide with mid-cycle vincristine (ICE-V) versus standard chemotherapy (C) in patients with small cell lung cancer (SCLC) and good performance status (PS): results of an MRC randomized trial (LU21)

Lung Cancer ◽

10.1016/s0169-5002(03)91933-7 ◽

2003 ◽

Vol 41 ◽

pp. S80 ◽

Cited By ~ 2

Author(s):

Nick Thatcher ◽

Wendi Qian ◽

David J. Girling

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Trial ◽

Cell Lung Cancer ◽

Performance Status ◽

Small Cell ◽

Small Cell Lung ◽

Standard Chemotherapy ◽

Good Performance Status

Download Full-text

Moderate dose-intensive chemotherapy for patients with non-small cell lung cancer: randomized trial, can it improve survival of patients with good performance status?

Oncology Reports ◽

10.3892/or.6.5.1045 ◽

1999 ◽

Cited By ~ 2

Author(s):

M Masutani ◽

I Tsujino ◽

T Fujie ◽

M Yamaguchi ◽

K Miyagi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Trial ◽

Cell Lung Cancer ◽

Performance Status ◽

Small Cell ◽

Intensive Chemotherapy ◽

Small Cell Lung ◽

Moderate Dose ◽

Good Performance Status

Download Full-text

ACR Appropriateness Criteria® Nonsurgical Treatment for Non-Small-Cell Lung Cancer: Good Performance Status/Definitive Intent

Current Problems in Cancer ◽

10.1016/j.currproblcancer.2010.04.001 ◽

2010 ◽

Vol 34 (3) ◽

pp. 228-249 ◽

Cited By ~ 7

Author(s):

Richard M. Gewanter ◽

Kenneth E. Rosenzweig ◽

Joe Yujiao Chang ◽

Roy Decker ◽

Sarita Dubey ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Small Cell ◽

Nonsurgical Treatment ◽

Small Cell Lung ◽

Appropriateness Criteria ◽

Good Performance Status ◽

Acr Appropriateness Criteria

Download Full-text

PIONEER: A Phase III Randomized Trial of Paclitaxel Poliglumex Versus Paclitaxel in Chemotherapy-Naive Women with Advanced-Stage Non-Small-Cell Lung Cancer and Performance Status of 2

Clinical Lung Cancer ◽

10.3816/clc.2006.n.027 ◽

2006 ◽

Vol 7 (6) ◽

pp. 417-419 ◽

Cited By ~ 42

Author(s):

Kathy S. Albain ◽

Chandra P. Belani ◽

Philip Bonomi ◽

Kenneth J. O'Byrne ◽

Joan H. Schiller ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Trial ◽

Cell Lung Cancer ◽

Performance Status ◽

Small Cell ◽

Phase Iii ◽

Advanced Stage ◽

Small Cell Lung ◽

And Performance

Download Full-text

142: CONVERT – An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS)

Lung Cancer ◽

10.1016/s0169-5002(17)30192-7 ◽

2017 ◽

Vol 103 ◽

pp. S64

Author(s):

C. Faivre-Finn ◽

M. Snee ◽

L. Ashcroft ◽

W. Appel ◽

F. Barlesi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Randomised Trial ◽

Small Cell ◽

Small Cell Lung ◽

Once Daily ◽

Limited Stage ◽

Good Performance Status

Download Full-text

P3-083: Erlotinib as a single agent in the treatment of patients with advanced or metastatic non-small cell lung cancer (NSCLC) and good performance status

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000284059.26609.7e ◽

2007 ◽

Vol 2 (8) ◽

pp. S714

Author(s):

Pilar Garrido ◽

Manuel Cobo ◽

Montserrat Doménech ◽

Romá Bastús ◽

Antonio Galán ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Performance Status ◽

Single Agent ◽

Small Cell ◽

Small Cell Lung ◽

Good Performance Status

Download Full-text

Skin rash and good performance status (PS) predict improved survival with gefitinib for patients with advanced non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7097 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7097-7097 ◽

Cited By ~ 2

Author(s):

M. K. Mohamed ◽

S. Ramalingam ◽

Y. Lin ◽

W. E. Gooding ◽

W. Cronin ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Skin Rash ◽

Cell Lung Cancer ◽

Performance Status ◽

Small Cell ◽

Small Cell Lung ◽

Good Performance Status

Download Full-text

A phase II randomized trial of docetaxel weekly or every 3 weeks in elderly and/or poor performance status (PS) patients (pts) with advanced non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7057 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7057-7057 ◽

Cited By ~ 7

Author(s):

R. Lilenbaum ◽

M. Rubin ◽

J. Samuel ◽

L. Boros ◽

T. Chidiac ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Trial ◽

Phase Ii ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung

Download Full-text

A phase II randomized trial of docetaxel weekly or every 3 weeks in elderly and/or poor performance status (PS) patients (pts) with advanced non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7057 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7057-7057 ◽

Cited By ~ 3

Author(s):

R. Lilenbaum ◽

M. Rubin ◽

J. Samuel ◽

L. Boros ◽

T. Chidiac ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Randomized Trial ◽

Phase Ii ◽

Cell Lung Cancer ◽

Performance Status ◽

Poor Performance ◽

Small Cell ◽

Poor Performance Status ◽

Small Cell Lung

Download Full-text